NCT03118908View on ClinicalTrials.gov

Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

October 10, 2017

Study Completion Date

October 10, 2017

Conditions
Climacteric SyndromeMenopause
Interventions
DIETARY_SUPPLEMENT

Amberen

Amberen is a succinate-based dietary supplement previously shown to help provide relief for common menopausal symptoms.

DIETARY_SUPPLEMENT

Smart B

Smart B contains vitamins B1, B2, B6, B9, B12 and sodium fumarate.

DIETARY_SUPPLEMENT

Placebo

Placebo capsules are identical to Amberen and Smart B capsules.

Trial Locations (1)

119991

Sechenov First Moscow Medical University, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT03118908 - Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome | Biotech Hunter | Biotech Hunter